Gable, DR and Hurel, SJ and Humphries, SE (2006) Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease. ATHEROSCLEROSIS , 188 (2) 231 - 244. 10.1016/j.atherosclerosis.2006.02.010.
Full text not available from this repository.
The increasing prevalence of obesity and metabolic syndrome/insulin resistance has attracted considerable interest due to their identification as risk factors for cardiovascular disease and, hence, targets for cardiovascular disease prevention. This review focuses on adiponectin, the most profusely secreted protein from adipose tissue, which itself is being increasingly recognised as an important and very active endocrine organ, secreting a wide range of biologically active substances known as adipokines or adipocytokines. Adiponectin has been demonstrated to have insulin sensitising effects, and secretion of adiponectin is reduced as adipose tissue mass increases. Adiponectin has also been demonstrated to have anti-inflammatory and anti-atherogenic properties, and is independently associated with cardiovascular disease. The evidence that suggests adiponectin plays a role in the relationship between obesity and insulin resistance, and also insulin resistance and cardiovascular disease, is examined. Variation in the adiponectin gene is one tool to determine whether this relationship is causal. The association of identified variants with human disease, specifically obesity and its consequences, type 2 diabetes and cardiovascular disease is reviewed. This data may enable patients at greater risk of the adverse effects of obesity to be identified and, as such, benefit from more targeted therapy of its consequences. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
|Title:||Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease|
|Keywords:||adiponectin, single nucleotide polymorphism, metabolic syndrome, type 2 diabetes mellitus, cardiovascular disease, CORONARY-ARTERY-DISEASE, ACTIVATED PROTEIN-KINASE, TYPE-2 DIABETIC-PATIENTS, SINGLE-NUCLEOTIDE POLYMORPHISM, IMPAIRED GLUCOSE-TOLERANCE, VASCULAR ENDOTHELIAL-CELLS, COMPLEMENT-RELATED PROTEIN, FASTING SERUM ADIPONECTIN, ADIPOCYTE-DERIVED PROTEIN, NONALCOHOLIC FATTY LIVER|
|UCL classification:||UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science|
Archive Staff Only: edit this record